ARC
JAZZ icon

Absolute Return Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Absolute Return Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,807
Closed -$485K – 620
2015
Q1 		$485K Buy
2,807
+151
+6% +$25.9K 0.01% 489
2014
Q4 		$435K Sell
2,656
-734
-22% -$122K 0.01% 541
2014
Q3 		$544K Sell
3,390
-2,587
-43% -$398K 0.01% 571
2014
Q2 		$879K Buy
+5,977
New +$829K 0.01% 690

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Absolute Return Capital's JAZZ Position: Q2 2015 in Review

Absolute Return Capital sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2015, closing a stake of 2,807 shares — an estimated $485K sold.

Absolute Return Capital first reported a position in JAZZ in Q2 2014 and held it in 4 quarters. The position peaked at $879K in Q2 2014. 373 funds tracked by Wall St. Rank hold JAZZ as of Q2 2015.

  • Absolute Return Capital reported no remaining Jazz Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Absolute Return Capital sold 2,807 Jazz Pharmaceuticals shares in Q2 2015, an estimated $485K.
  • Absolute Return Capital first reported a position in Jazz Pharmaceuticals in Q2 2014 and held it in 4 quarters.
  • Absolute Return Capital's Jazz Pharmaceuticals position peaked at $879K in Q2 2014.
  • 373 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2015.

Based on Absolute Return Capital's 13F filing for Q2 2015, filed 14 Aug 2015.